248 related articles for article (PubMed ID: 15736606)
41. Re: Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
Foro P; Algara M; Rodriguez N; Sanz J
J Natl Cancer Inst; 2006 Mar; 98(5):364; author reply 365. PubMed ID: 16507836
[No Abstract] [Full Text] [Related]
42. The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases.
Tomblyn M
Cancer Control; 2012 Apr; 19(2):137-44. PubMed ID: 22487976
[TBL] [Abstract][Full Text] [Related]
43. Radiation therapy and radio-nuclides for palliation of bone pain.
Crook J
Urol Clin North Am; 2006 May; 33(2):219-26, vii. PubMed ID: 16631460
[TBL] [Abstract][Full Text] [Related]
44. Audit reduces the reluctance to use single fractions for painful bone metastases.
Booth M; Summers J; Williams MV
Clin Oncol (R Coll Radiol); 1993; 5(1):15-8. PubMed ID: 7678748
[TBL] [Abstract][Full Text] [Related]
45. Quantitative bone single-photon emission computed tomography for prediction of pain relief in metastatic bone disease treated with rhenium-186 etidronate.
Israel O; Keidar Z; Rubinov R; Iosilevski G; Frenkel A; Kuten A; Betman L; Kolodny GM; Yarnitsky D; Front D
J Clin Oncol; 2000 Jul; 18(14):2747-54. PubMed ID: 10894875
[TBL] [Abstract][Full Text] [Related]
46. Preliminary results of the use of Re-186-HEDP for palliation of pain in patients with metastatic bone disease.
Giannakenas C; Kalofonos HP; Apostolopoulos DJ; Zarakovitis J; Kosmas C; Vassilakos PJ
Am J Clin Oncol; 2000 Feb; 23(1):83-8. PubMed ID: 10683086
[TBL] [Abstract][Full Text] [Related]
47. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
Leondi AH; Souvatzoglou MA; Rapti AS; Leontopoulou SA; Papadaki EK; Datseris EI; Anagnostopoulou US; Zerva CJ
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
[TBL] [Abstract][Full Text] [Related]
48. Radiopharmaceuticals: when and how to use them to treat metastatic bone pain.
Paes FM; Ernani V; Hosein P; Serafini AN
J Support Oncol; 2011; 9(6):197-205. PubMed ID: 22055888
[TBL] [Abstract][Full Text] [Related]
49. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
[TBL] [Abstract][Full Text] [Related]
50. The Vienna protocol and perspectives in radionuclide therapy.
Sinzinger H; Palumbo B; Ozker K
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):420-30. PubMed ID: 21738115
[TBL] [Abstract][Full Text] [Related]
51. [Treatment of pains from bone metastases with 90Y (author's transl)].
Kutzner J; Dähnert W; Schreyer T; Grimm W; Brod KH; Becker M
Nuklearmedizin; 1981 Oct; 20(5):229-35. PubMed ID: 6171780
[TBL] [Abstract][Full Text] [Related]
52. Application of rhenium-188 HEDP in bone metastases therapy.
Scheffler J; Derejko M; Bandurski T; Romanowicz G
Nucl Med Rev Cent East Eur; 2003; 6(1):55-7. PubMed ID: 14600935
[TBL] [Abstract][Full Text] [Related]
53. Nursing management of the patient with bone metastases.
Struthers C; Mayer D; Fisher G
Semin Oncol Nurs; 1998 Aug; 14(3):199-209. PubMed ID: 9718645
[TBL] [Abstract][Full Text] [Related]
54. Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.
Srivastava SC; Atkins HL; Krishnamurthy GT; Zanzi I; Silberstein EB; Meinken G; Mausner LF; Swailem F; D'Alessandro T; Cabahug CJ; Lau Y; Park T; Madajewicz S
Clin Cancer Res; 1998 Jan; 4(1):61-8. PubMed ID: 9516953
[TBL] [Abstract][Full Text] [Related]
55. Palliative radiotherapy for prostate cancer.
Boyer MJ; Salama JK; Lee WR
Oncology (Williston Park); 2014 Apr; 28(4):306-12. PubMed ID: 24839802
[TBL] [Abstract][Full Text] [Related]
56. The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases.
Kasalický J; Krajská V
Eur J Nucl Med; 1998 Oct; 25(10):1362-7. PubMed ID: 9818274
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness of hypofractionated radiotherapy in painful bone metastases. Two prospective studies with 1 x 4 Gy and 4 x 4 Gy.
Bremer M; Rades D; Blach M; Krenkel B; Karstens JH
Strahlenther Onkol; 1999 Aug; 175(8):382-6. PubMed ID: 10481769
[TBL] [Abstract][Full Text] [Related]
58. Fluorodeoxyglucose Uptake on Positron Emission Tomography Is a Useful Predictor of Long-Term Pain Control After Palliative Radiation Therapy in Patients With Painful Bone Metastases: Results of a Single-Institute Prospective Study.
Tahara T; Fujii S; Ogawa T; Michimoto K; Fukunaga T; Tanino T; Uchida N; Matsuki T; Sakamoto H
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):322-8. PubMed ID: 26853340
[TBL] [Abstract][Full Text] [Related]
59. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma.
Lee J; Hodgson D; Chow E; Bezjak A; Catton P; Tsuji D; O'Brien M; Danjoux C; Hayter C; Warde P; Gospodarowicz MK
Cancer; 2005 Nov; 104(9):1894-900. PubMed ID: 16177996
[TBL] [Abstract][Full Text] [Related]
60. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
